puffing of the cheeks
Dec 25, 2023 · Common side effects of selegiline may include: redness or itching where the patch is worn; headache; diarrhea, upset stomach, dry mouth; sleep problems (insomnia); rash; or
Transdermal selegiline is contraindicated for use in children <12 years of age
If any of Selegiline prevents the breakdown of a chemical in your brain called dopamine (DO pa meen)
Contraindications
Dizziness, abdominal pain, dry mouth, nausea, stomach upset, trouble sleeping, and headache may occur
selegiline generic Drug Monograph Black Box Warnings Adult Dosing Peds Dosing Contraindications/Cautions Drug Interactions Adverse Reactions Safety/Monitoring
) One case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a sympathomimetic medication
Dosage Forms
25 mg; 6 mg/24 hr; 9 mg/24 hr; 12 mg/24 hr Usual Adult
swelling or inflammation of the mouth
Selegiline is a medication used in the treatment of Parkinson’s disease, a movement disorder caused by the degeneration of nerve cells (neurons) in certain regions of the brain
It is usually applied once a day and left in place for 24 Common side effects of selegiline may include: redness or itching where the patch is worn; headache; diarrhea, upset stomach, dry mouth; sleep problems (insomnia); rash; or
Contraindications
It is available as a skin (transdermal) patch, sold under the name Cautions for Selegiline Contraindications
John’s wort (Hypericum
Selegiline is contraindicated for use with meperidine
Initially 5 mg once daily for 2–4 weeks, then increased if tolerated to 10 mg daily, dose to be taken in the morning
Selegiline is contraindicated for use with meperidine
It works by increasing the amount of dopamine in your brain, a substance which helps manage body movements and coordination
This medicine is a monoamine oxidase inhibitor (MAOI)
Uncontrolled hypertension has been reported when taking the recommended dose of swallowed selegiline and a sympathomimetic medication (ephedrine)
The first was the elucidation of the novel pharmacological properties of selegiline as a selective MAO-B inhibitor by Knoll and Magyar and the original idea of Riederer and Youdim, supported by Birkmayer, to explore its effect in parkinsonian patients with on–off phases
Dizziness, abdominal pain, dry mouth, nausea, stomach upset, trouble sleeping, and headache may occur
For oral dosage form (oral disintegrating tablets): Adults—At first, 1
Dopamine; Monoamine oxidase type B inhibitors; Neuroprotection; Parkinson’s disease; Selegiline
risk of profound CNS and resp
Although the meta-analysis based on the most selective literature search revealed that both drugs were equally effective in controlling motor symptoms , another suggested a possible difference between the two MAO-B inhibitors in favor of selegiline, in terms of reduction in daily levodopa dose